Searching journal content for treatment response (as phrase) in full text.

Displaying results 1-10 of 79
For checked items
  1. ...treatment response or prognosis of CRPC patients 70 (Lallous, et al. 2016; Steinestel, et al. 2015). In some CRPC patients, the disease will evolve 71 Page 3 of 38 to a highly aggressive and treatment-resistant CRPC, characterized by acquired 72 neuroendocrine cell-specific phenotype and loss of AR, ~~~
  2. ...treatment response (DRS low risk), whereas remaining 20.2% of patients were restratified at as DRS high-risk (among them 3.3% with biochemical incomplete response, 6.4% with incomplete structural response and 10.5% with indeterminate response). At the final follow-up, 83.6% of patients were free of ~~~
  3. ...treatment response in prostate cancer. Nature Reviews Clinical Oncology 11 401–412. (doi:10.1038/nrclinonc.2014.82) Miyamoto DT, Zheng Y, Wittner BS, Lee RJ, Zhu H, Broderick KT, Desai R, Fox DB, Brannigan BW, Trautwein J, et al. 2015 RNA-Seq of single prostate CTCs implicates noncanonical Wnt signa ~~~
  4. ...treatment response ~~~
  5. ...treatment response and outcome of NMTC patients was investigated. With regard to the NFKB1 rs4648068 SNP, no statistically significant differences were found in any of the patient cohorts for any of the selected clinical parameters. Interestingly, however, the NFKBIA rs2233406 SNP was significantly ~~~
  6. ...treatment response after PRRT. 354 Dutch patients with GEPNETs who were treated with 177Lu-DOTATATE between March 2000 and December 2011 were retrospectively selected. Liver function parameters and chromogranin A were measured before each therapy and in follow-up. Anatomical imaging was performed be ~~~
  7. ...treatment response NCT02391051 Interventional University of Erlangen-Nürnberg Medical School Focal brachytherapy in patients with selected ‘low-risk’ prostate cancer – a phase-II-trial R165Review B Smith et al. MicroRNA toward cancer patient care DOI: 10.1530/ERC-16-0525 http://.endocrinology-journa ~~~
  8. ...treatment response with diffusion-weighted MRI. Journal of Magnetic Resonance Imaging 32 2–16. (doi:10.1002/jmri.22167) Wiedemann T, Peitzsch M, Qin N, Neff F, Ehrhart-Bornstein M, Eisenhofer G & Pellegata NS 2016 Morphology, biochemistry and pathophysiology of MENX-related pheochromocytoma recapitu ~~~
  9. ...treatment response ~~~
  10. ...treatment response and explore at which points PDTX models may be introduced into the drug discovery process. Tumour heterogeneity Complex patterns of inter- and intra-tumour heterogeneity are a defining feature of human malignancy. Although the past few years have seen an unprecedented increase in ~~~
For checked items